Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Huntington Ingalls Executive Receives 11 Derivative Securities (NYSE: HII)

HUNTINGTON INGALLS INDUSTRIES, INC. (NYSE: HII) awarded Hughes Edmond E. Jr. 11 derivative securities on Sep. 11, 2026. Edmond is the former vice president and chief human resources officer of Huntington Ingalls Industries.

Vinay Lochav | 15 September 2026

Huntington Ingalls Industries Awards Director 17 Shares at $0 (NYSE: HII)

HUNTINGTON INGALLS INDUSTRIES, INC. (NYSE: HII) awarded director Jimenez Frank R 17 shares at $0 per share on 11 September 2026. The transaction was recorded under code A.

Vinay Lochav | 15 September 2026

Elicio Therapeutics (NASDAQ: ELTX) Sets 2026 Annual Meeting for November 12

Elicio Therapeutics, Inc. (NASDAQ: ELTX) has set November 12, 2026, for its annual meeting of stockholders. The company will provide the meeting’s exact time, location and voting matters in its proxy statement.

Vinay Lochav | 15 September 2026

Why NAKA, DCGO, TNON, BTMD and LFMD Could Be Key Healthcare Services Names on the Nasdaq Radar

● Nakamoto, formerly KindlyMD, ended its healthcare clinic operations on June 19, 2026 and now operates as aBitcointreasury holding roughly 4,467 Bitcoin valued at about $261.5 million as of the second quarter of 2026.

Vinay Lochav | 15 September 2026

Emergent BioSolutions (NYSE: EBS) CEO Presents Investor Plan September 14

Emergent BioSolutions Inc. (NYSE: EBS) Chief Executive Joseph C. Papa presented the company’s investor slides at the H.C. Wainwright GlobalInvestmentConference on September 14. The material set out management’s public-health focus and operating priorities.

Vinay Lochav | 15 September 2026

Why NUTX, BDSX, PARK, LMRI and BLLN Could Be Key Healthcare Services Names on the Nasdaq Composite Radar in September 2026

● Nutex Health swung to second-quarter 2026Net Incomeof $65.8 million and diluted EPS of $9.38, from a $17.7 million loss a year earlier, even asRevenuefell 13.6% to $210.8 million after a HaloMD billing-partner amendment and lower federal arbitration fees.

Vinay Lochav | 15 September 2026

EnVVeno Medical Director Sells 11 Shares at $11.21 (NASDAQ: NVNO)

EnVVeno Medical Corp (NASDAQ: NVNO) director Duhay Francis sold 11 shares at $11.21 per share on 11 September 2026. Following the transaction, Francis owned 2,351 shares of enVVeno Medical Corp.

Vinay Lochav | 15 September 2026

Guardant Health Director Exercises 1,651 Options at $0 (NASDAQ: GH)

Guardant Health, Inc. (NASDAQ: GH) director Azar Alex M II exercised options for 1,651 shares at $0 per share on 12 September 2026.

Vinay Lochav | 15 September 2026

QURE, XNCR, RANI, PYXS and DTIL Bring Biotech and Health Technology Into Focus for the Nasdaq Composite in September 2026

TheNasdaqComposite is broad enough to hold almost every Nasdaq-listed common stock, which means it also holds the small and mid-cap biotech names where the market's real drug-development risk lives. uniQure (NASDAQ:QURE), Xencor (NASDAQ:XNCR), Rani Therapeutics (NASDAQ:RANI), Pyxis Oncology (NASDAQ:PYXS) and Precision BioSciences (NASDAQ:DTIL) span …

Vinay Lochav | 15 September 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) Executive Sells 1,200 Shares at $240.94

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) executive Patil Neena M sold 1,200 shares at $240.94 per share on 10 September 2026, leaving her with 47,671 shares. The transaction represented about 2.5% of her prior shares holding.

Vinay Lochav | 15 September 2026
Support

Hi! How can we help you today?

Loading…